Protective effect of tumor necrosis factor α antibody on experimental necrotizing enterocolitis in the rat

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine · 2001 · 3.7K citations · Full text

Medicine, Immunology, Pharmacotherapy +16

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.2K citations · Full text

Pharmacy, Immunology, Inflammation +12

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease

Jan M. H. van den Brande, Henri Braat, Gijs R. van den Brink et al. · Gastroenterology · 2003 · 725 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

Bernard J. Scallon · Cytokine · 1995 · 682 citations

Life Sciences, Immunology, Molecular Biology +12